Find uplifting stories about heroes, innovations, and solutions
43 results for "semaglutide"
Millions who avoid needles can now access a breakthrough weight loss medication in pill form. The FDA just approved oral semaglutide and a higher-dose option, making effective obesity treatment easier than ever.
A breakthrough study of 95,000 patients found that semaglutide, the active ingredient in Ozempic and Wegovy, significantly reduces the risk of worsening mental health in people with diabetes and depression. The discovery could offer hope for millions living with both conditions.
A major new study brings surprising good news for people taking the diabetes medication semaglutide (Ozempic). Despite losing more weight than users of other medications, they experienced 15% fewer bone fractures.
A diabetes medication known for weight loss is proving to be a powerful ally for kidney and heart health. New research shows semaglutide can slow kidney disease progression and save lives.
Semaglutide, the active ingredient in Ozempic and Wegovy, helped people with obesity reduce heavy drinking days by 41% in a groundbreaking six-month trial. This marks the first randomized study testing GLP-1 drugs for alcohol use disorder treatment.
More people with obesity are getting treatment now than at any point in the past 20 years, thanks to breakthrough medications like semaglutide. A major study tracking over 200,000 patients shows how policy changes and new drugs transformed access to life-changing care.
Scientists discovered that semaglutide, the drug behind Ozempic and Wegovy, can rebuild damaged cartilage in people with arthritis even without weight loss. The breakthrough hints at a powerful new treatment for millions suffering from joint pain.
A groundbreaking trial found that semaglutide, the popular weight loss drug, significantly reduced alcohol cravings and heavy drinking days in people battling both obesity and alcohol addiction. The discovery could transform treatment options for millions worldwide struggling with alcohol use disorder.
A breakthrough study shows the diabetes drug semaglutide helps older adults lose significant weight safely while improving heart health. Nearly half of participants over 65 achieved at least 15% weight loss in just over a year.
The diabetes and weight-loss medication semaglutide (Ozempic/Wegovy) just proved effective at treating alcohol-use disorder in a major clinical trial. Millions struggling with problem drinking now have a new treatment option their doctors already know how to prescribe.
Weight loss drug semaglutide shows unexpected mental health benefits in 100,000-person study. Depression, anxiety, and addiction rates plummeted during treatment periods.
A clinical trial shows semaglutide, the drug in Ozempic and Wegovy, slowed biological aging markers by 9% in just 32 weeks. Scientists say it's the first randomized evidence that a widely available medication may slow cellular aging processes.
Danish researchers found that popular GLP-1 drugs like semaglutide reduced asthma flare-ups by a quarter and cut inhaler dependence by 14%. The breakthrough suggests these medications do more than just help with weight loss.
New research reveals genetic variants that explain why weight-loss drugs like semaglutide help some people lose 25% of their body weight while others see minimal results. The discovery could pave the way for more personalized treatments.
Researchers have created the first sex-specific brain map showing where popular weight-loss drugs like semaglutide work differently in females versus males. This breakthrough could explain why women often respond better to these treatments and pave the way for more personalized medicine.
Life-changing weight loss and diabetes drugs could soon be made for as little as $3 per month, making them affordable for millions who've been priced out. Patents expire this month in several countries, opening the door to low-cost versions.
Scientists at UC San Diego discovered that popular weight loss medications like Ozempic may actually slow biological aging by reprogramming cells and reducing inflammation. The breakthrough finding could transform how we approach healthy aging for millions of Americans.
Scientists are developing breakthrough medications that could let people lose weight without sacrificing muscle mass. The experimental treatments offer hope for millions using Ozempic and similar drugs who worry about losing strength.
Ozempic and similar medications may heal arthritis, liver disease, and more by resetting the immune system, not just through weight loss. Scientists are discovering these drugs work throughout the body to reduce harmful inflammation while keeping infection-fighting power strong.
Starting this weekend, affordable generic versions of Ozempic and Wegovy will reach countries representing 40% of the world's population. Prices could eventually drop to $15 per month, making the life-changing medication accessible to millions who couldn't afford it before.
Showing 20 of 43